Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase

European Journal of Endocrinology

Volumn 147, Issue 5, 2002, Pages 689-700

  Anfossi, Giovanni ^a   Massucco, Paola ^a   Mattiello, Luigi ^a   Balbo, Alessandra ^a   Russo, Isabella ^a   Doronzo, Gabriella ^a   Rolle, Luigi ^a   Ghigo, Dario ^a   Fontana, Dario ^a   Bosia, Amalia ^a   Trovati, Mariella ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ARGININE; CALCIUM; CALCIUM IONOPHORE; CELL PROTEIN; CITRULLINE; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; FORSKOLIN; GUANYLATE CYCLASE; ILOPROST; INSULIN; IONOMYCIN; MESSENGER RNA; N(G) METHYL DEXTRO ARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE; RECOMBINANT HUMAN INSULIN; WORTMANNIN;

ADULT; ARTICLE; BLOOD VESSEL TONE; CELL CULTURE; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME INHIBITION; ERECTILE DYSFUNCTION; HEMODYNAMICS; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; PENILE BLOOD VESSEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

EID: 0036854506     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470689     Document Type: Article

References (52)

1. Schiavi RC, Stimmel BB, Mandeli J & Rayfield EJ. Diabetes mellitus and male sexual function: a controlled study. Diabetologia 1993 36 745-751.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ & McKinlay JB. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. Journal of Urology 1994 151 54-61.
3. Fedele D, Coscelli C, Cucinotta D, Forti G, Santeusanio F, Viaggi S et al. Incidence of erectile dysfunction in Italian men with diabetes. Journal of Urology 2001 166 1368-1371.
4. Andersson KE & Stief CG. Neurotransmission and the contraction and relaxation of penile erectile tissue. World Journal of Urology 1997 15 14-20.
5. Andersson KE & Wagner G. Physiology of penile erection. Physiological Reviews 1995 75 191-236.
6. McKenna KE. Central control of penile erection. International Journal of Impotence Research 1998 10 (Suppl 1) S25-S34.
7. Schultheiss D & Stief CG. Physiology and pathophysiology of erection: consequences for present medical therapy of erectile dysfunction. Andrologia 1999 31 (Suppl 1) 59-64.
8. Anderssson HE. Neurotransmitters: central and peripheral mechanisms. International Journal of Impotence Research 2000 12 S26-S33.
9. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukoto JM & Raijfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochemical and Biophysical Research Communications 1990 170 843-850.
10. Kim N, Azadzoi KM, Goldstein I & Saenz de Tajeda I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. Journal of Clinical Investigation 1991 88 112-118.
11. Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK & Snyder SH. Nitric oxide: a phvsiological mediator of penile erection. Science 1992 257 401-403.
12. Raifer J, Aronson WJ, Bush PA, Dorey FJ & Ignarro LJ. Nitric oxide as a mediator of the corpus cavernosum in response to noncholinergic, nonadrenergic neurotransmission. New England Journal of Medicine 1992 326 90-94.
13. Ehmke H, Junemann KP, Mayer B & Kummer W. Nitric oxide synthase and vasoactive intestinal polypeptide colocalization in neurons innervating the human penile circulation. International Journal of Impotence Research 1995 7 147-156.
14. Bush PA, Aronson WJ, Buga GM, Reifer J & Ignarro LJ. Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. Journal of Urology 1992 147 1650-1655.
15. Bush PA, Aronson WJ, Rajfer J & Ignarro LJ. Comparison of nonadrenergic-noncholinergic and nitric oxide-mediated relaxation of corpus cavernosum. International Journal of Impotence Research 1992 4 85-93.
16. Knispel HH, Goessl C & Beckmann R. Nitric oxide mediates relaxation in rabbit and human corpus cavernosum smooth muscle. Urological Research 1992 20 253-257.
17. Burnett AL. Role of nitric oxide in the physiology of erection. Biology of Reproduction 1995 52 485-489.
18. Burnett AL. Nitric oxide in the penis: physiology and pathology. Journal of Urology 1997 157 320-324.
19. Simonsen V, Prieto D, Delgado JA, Hernandez M, Resel L, Saenz de Tejade IS et al. Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. Clinical Science 1997 92 269-275.
20. Christ GJ. The penis as a vascular organ: the importance of corporal smooth muscle tone in the control of erection. Urologic Clinics of North America 1995 22 727-745.
21. Lue TF & Dahiya R. Molecular biology of erectile function and dysfunction. Molecular Urology 1997 1 55-64.
22. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. Journal of Urology 1996 155 802-815.
23. Taher A, Meyer M, Stief CG, Jonas U & Forssmann WG. Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World Journal of Urology 1977 15 32-35.
24. Saenz de Tejada I, Blanco R, Goldstein I, Azadzoi K, Des las Morenas A, Krane RJ et al. Cholinergic neurotransmission in human corpus cavernosum. I. Response of isolated tissue. American Journal of Physiology 1988 254 H459-H476.
25. Rembold CM. Regulation of contraction and relaxation in arterial smooth muscle. Hypertension 1992 20 129-137.
26. Palmer LS, Valcic M, Melman A, Giraldi A, Wagner G & Christ GJ. Characterization of cyclic AMP accumulation in cultured human corpus smooth muscle cells. Journal of Urology 1994 152 1308-1314.
27. Somlyo AP & Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994 372 231-236.
28. Stief CG, Noack T & Andersson KE. Signal transduction in cavernous smooth muscle. World Journal of Urolology 1997 15 27-31.
29. Krall JF, Fittinoff M & Rajfer J. Characterization of cyclic nucleotide and inositol-1,4,5-triphosphate-sensitive calcium-exchange activity of smooth muscle cells cultured from the human corpora cavernosa. Biology of Reproduction 1988 39 913-922.
30. Maggi M, Filippi S, Ledda F, Magini A & Forti G. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. European Journal of Endocrinology 2000 143 143-154.
31. Walsh MP. Regulation of vascular smooth muscle. Canadian Journal of Physiology and Pharmacoloqy 1994 72 919-936.
32. Abdel-Latif AA. Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Experimental Biology and Medicine 2001 226 153-163.
33. Trovati M, Massucco P, Mattiello L, Costamagna C, Aldieri E, Cavalot F et al. Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3′:5′-cyclic monophosphate and adenosine 3′:5′-cyclic monophosphate concentrations. Diabetologia 1999 42 831-839.
34. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L & Trovati M. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the anti-aggregating effects of the stable prostacyclin analogue Iloprost. Prostaglandins, Leukotrienes and Essential Fatty Acids 1993 49 839-845.
35. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L & Trovati M. Effect of forskolin and organic nitrates on aggregation and intracellular cyclic nucleotide content in human platelets. General Pharmacology 1994 25 1093-1100.
36. Maurice DH & Haslam RJ. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Molecular Pharmacology 1990 37 671-681.
37. Mittal KC & Murad F. Formation of adenosine 3′,5′-monophosphate by preparations of guanylate cyclase from rat liver and other tissues. Journal of Biological Chemistry 1977 252 3136-3140.
38. Trovati M, Massucco P, Mattiello L, Cavalot F, Mularoni E, Hahn A et al. Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetologia 1995 38 936-941.
39. Trovati M, Massucco P, Mattiello L, Cavalot F, Mularoni EM, Hahn AW et al. Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects. Diabetologia 1996 39 1156-1164.
40. Steinberg HO, Brechtel G, Johnson A, Fineberg N & Baron A. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. Journal of Clinical Investigation 1994 94 1172-1179.
41. Scherrer U, Randin D, Vollenwieder L & Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. Journal of Clinical Investigation 1994 94 2511-2515.
42. Zeng G & Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. Journal of Clinical Investigation 1996 98 894-898.
43. Trovati M, Anfossi G, Massucco P, Mattiello L, Costamagna C, Piretto V et al. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3′,5′-cyclic monophosphate and adenosine-3′,5′-cyclic monophosphate. Diabetes 1997 46 742-749.
44. Bloch W, Klotz T, Sedleczek P, Zumbe J, Engelmann U & Addicks K. Evidence for the involvement of endothelial nitric oxide synthase from smooth muscle cells in the erectile function of the corpus cavernosum. Urological Research 1998 26 129-135.
45. Stanarius A, Uckert S, Machtens SA, Stief CG, Wolf G & Jonas U. Immunocytochemical distribution of nitric oxide synthase in the human corpus cavernosum: an electron microscopical study using the tyramide signal amplification technique. Urological Research 2001 29 168-172.
46. Ghigo D, Alessio P, Foco A, Bussolino F, Costamagna C, Heller R et al. Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. American Journal of Physiology 1993 265 C728-C732.
47. Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Analytical Biochemistry 1987 162 156-159.
48. Marsden PA, Schappert KT, Chen H-S, Flowers M, Lamas S, Sundell CL et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Letters 1992 307 287-293.
49. Maniatis T, Fritsch EF & Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbour Laboratory Press, 1982.
50. Palmer RMJ, Ferrige AG & Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochemical and Biophysical Research Communications 1989 158 348-352.
51. Cahn D, Melman A, Valcic, M & Christ GJ. Forskolin: a promising new adjunct to intracavernous pharmacotherapy. Journal of Urology 1996 155 1789-1794.
52. Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P et al. Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. Journal of Urology 1997 158 1752-1758.